European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study

Robert W. Foley, Robert M. Maweni, Laura Gorman, Keefe Murphy, Dara J. Lundon, Garrett Durkan, Richard Power, Frank O'Brien, Kieran J. O'Malley, David J. Galvin, T. Brendan Murphy, R. William Watson

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'European Randomised Study of Screening for Prostate Cancer (ERSPC) risk calculators significantly outperform the Prostate Cancer Prevention Trial (PCPT) 2.0 in the prediction of prostate cancer: a multi-institutional study'. Together they form a unique fingerprint.

Medicine & Life Sciences